Literature DB >> 10715042

Arteriographic detection of renovascular disease in potential renal donors: incidence and effect on donor surgery.

E Neymark1, J M LaBerge, R Hirose, J S Melzer, R K Kerlan, M W Wilson, R L Gordon.   

Abstract

PURPOSE: To determine the arteriographic incidence and severity of renal arterial disease in potential renal donors and to evaluate the effect of identifying vascular abnormalities on subsequent donor surgery.
MATERIALS AND METHODS: The records of 716 potential living renal donors who underwent conventional arteriography were reviewed. Abnormal arteriograms were reexamined to characterize vascular disease, and the effect of identifying renovascular disease on subsequent donor surgery was ascertained with chart review.
RESULTS: Renovascular abnormalities were noted in the dictated reports in 78 patients (10.9%). The most common causes were fibromuscular dysplasia and atherosclerosis. The arteriograms of 64 patients were available for retrospective review. Abnormalities were characterized as minimal stenosis (<30% narrowing) in 42 patients and mild stenosis (30%-50% narrowing) in 19 of 61 patients with arteriographic abnormalities at retrospective review. In three patients, no significant abnormality was seen at retrospective review. The effect of detecting renovascular disease on donor selection was determined in 74 of the 78 patients. In 73 of these 74 patients (99%), detection of an abnormality directly affected donor surgery.
CONCLUSION: In this population of potential renal donors, the arteriographic incidence of renovascular disease (10.9%) was higher than previously reported. Although renovascular abnormalities were mild, their detection influenced the plan for donor surgery in almost all patients.

Entities:  

Mesh:

Year:  2000        PMID: 10715042     DOI: 10.1148/radiology.214.3.r00mr18755

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Renal intervention to treat hypertension.

Authors:  Rajan A G Patel; Christopher J White
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

Review 3.  Non-Atherosclerotic Vascular Disease in Women.

Authors:  Lee Joseph; Esther S H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-14

4.  Fibromuscular Dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-06

5.  One-stop preoperative assessment of renal vessels for living donors with 3.0 T non-contrast-enhanced magnetic resonance angiography: compared with computerized tomography angiography and surgical results.

Authors:  Xiaotian Li; Fangjie Xia; Lihua Chen; Xiaodong Zhang; Chunbai Mo; Wen Shen
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039

6.  CT angiography for living kidney donors: accuracy, cause of misinterpretation and prevalence of variation.

Authors:  Jee Won Chai; Whal Lee; Yong Hu Yin; Hwan Jun Jae; Jin Wook Chung; Hyeon Hoe Kim; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2008 Jul-Aug       Impact factor: 3.500

Review 7.  Current approaches to renovascular hypertension.

Authors:  Stephen C Textor
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

8.  Renal artery fibromuscular dysplasia in 2,640 renal donor subjects: a CT angiography analysis.

Authors:  Gavin A McKenzie; Gustavo S Oderich; Akira Kawashima; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2013-08-02       Impact factor: 3.464

Review 9.  The Diagnosis and Treatment of Fibromuscular Dysplasia: An Update for Cardiologists.

Authors:  Esther S H Kim; Maya Serhal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-06

Review 10.  Fibromuscular dysplasia.

Authors:  Pierre-François Plouin; Jérôme Perdu; Agnès La Batide-Alanore; Pierre Boutouyrie; Anne-Paule Gimenez-Roqueplo; Xavier Jeunemaitre
Journal:  Orphanet J Rare Dis       Date:  2007-06-07       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.